Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2026-01-01 @ 8:33 PM
Study NCT ID:
NCT03059251
Status:
COMPLETED
Last Update Posted:
2020-04-17
First Post:
2017-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Observational Study: Safety and Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in Argentina
Sponsor:
Hoffmann-La Roche